{
    "code": "02021826",
    "許可證字號": "衛署藥輸字第021826號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "101\/07\/24",
    "發證日期": "86\/07\/24",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202182608",
    "中文品名": "鹽酸鹽注射劑１２．５公絲\/公撮",
    "英文品名": "DOBUTAMINE HYDORCHLORIDE INJECTION 12.5MG\/ML",
    "適應症": "增強心肌收縮力而適用於短期治療，器質性心臟病、心臟外科手術引起心肌收縮力抑制而導致之心臟代賞能力衰竭。",
    "劑型": "270注射劑",
    "包裝": "盒裝 小瓶",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "DOBUTAMINE HCL, SODIUM METABISULFITE (SOD. PYROSULFITE)",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "620102S342  新加坡商赫士睿股份有限公司台灣分公司",
    "申請商地址": "台北市大安區敦化南路2段333號18樓",
    "主製造廠": {
        "製造廠名稱": "F460005000  HOSPIRA INC.",
        "製造廠廠址": "HIGHWAY (ALSO REFERRED TO AS HWY) 301 NORTH,ROCKY MOUNT,NORTH CAROLINA,27801 U.S.A.",
        "製造廠公司地址": "275 NORTH FIELD DRIVE, P.O. BOX 5045, LAKE FOREST, IL 60045-5045, USA",
        "製造廠國別": "UNITED STATES",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2404300210",
            "成分名稱": "DOBUTAMINE HCL",
            "含量描述": "12.5",
            "含量": "12.5000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "9600028300",
            "成分名稱": "SODIUM METABISULFITE (SOD. PYROSULFITE)",
            "含量描述": "0.22",
            "含量": "0.2200000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 020218260001.doc",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=02021826&Seq=001&Type=9"
        }
    ]
}